Food and Beverages, Food Technology and Food Processing · Published Aug 2026
Plant Breeding and CRISPR Plants Market
The global Plant Breeding and CRISPR Plants market was valued at USD 22,360.68 million in 2025 and is projected to reach USD 38,195.27 million by 2035, expanding at a CAGR of 5.5% over the forecast period. Growth is driven by increasing demand for high-yield, disease-resistant crops and advances in biotechnological breeding methods. Regulatory frameworks and investment in agricultural innovation further support market expansion.
Challenges include high R&D costs and public acceptance of genetically modified organisms. Opportunities lie in precision breeding and sustainable crop development.
Market size
Growth trajectory through 2035
Plant Breeding and CRISPR Plants Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2025
- 2025-Q1: Regulatory approval granted for first CRISPR-edited wheat variety in the United States, enabling commercialization.
-
2025
- 2025-Q2: Partnership announced between a leading agribusiness and a CRISPR startup to develop disease-resistant tomato varieties for greenhouse cultivation.
-
2025
- 2025-Q3: European Union updates regulatory framework for gene-edited crops, streamlining approval processes for certain traits.
Emerging opportunities added
- Precision Breeding for Climate Resilience Opportunities exist in developing crop varieties tailored to specific climatic conditions, such as drought or heat tolerance. This aligns with global sustainability goals and farmer needs.
- Integration with Digital Agriculture Combining CRISPR-based breeding with digital tools, such as AI and genomic data analytics, can enhance selection efficiency. This integration supports data-driven decision-making in plant breeding programs.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $22.36 Bn
- CAGR
- 5.50%
- Expansion
- 1.7×
Market shape
top segment · 59.5% share
- Leading region
- Asia Pacific
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High R&D Costs
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
2025-Q1: Regulatory approval granted for first CRISPR-edited wheat variety in the United States, enabling commercialization
+2 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 124-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Plant Breeding and CRISPR Plants Market today ($22.36 Bn base), and how fast will it grow at 5.5% CAGR through 2035?
- Which of Conventional Breeding, CRISPR-based Gene Editing, Marker-assisted Selection and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Cereals & Grains (e.g, wheat, rice applications, and which application is scaling fastest?
- How do Asia-Pacific, North America, Europe, Middle East & Africa compare on market share, growth rate, and regulatory posture?
- Where do Nestle, PepsiCo, Coca-Cola and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Demand for High-Yield Crops) and top restraints (led by High R&D Costs), with quantified CAGR impact?
- What regulatory shifts and 3 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Demand for High-Yield Crops Increasing global population and food security concerns drive demand for crops with improved yield potential. Conventional breeding methods are being supplemented by biotechnological approaches to meet these needs.
- Advancements in CRISPR Technology CRISPR-based gene editing enables precise trait modifications, reducing development timelines compared to traditional methods. This accelerates the introduction of disease-resistant and stress-tolerant crop varieties.
- Regulatory Support and Investment Governments and private entities are increasing funding for agricultural biotechnology. Supportive regulatory frameworks in key markets facilitate the commercialization of CRISPR-edited crops.
Restraints
Holding it back
- High R&D Costs The development of CRISPR-based plant varieties requires significant investment in research, testing, and regulatory compliance. This limits participation to well-capitalized organizations and may slow market penetration.
- Public Acceptance and Labeling Concerns Consumer skepticism regarding genetically modified organisms (GMOs) and labeling requirements pose challenges. Misconceptions about safety and environmental impact may hinder adoption in certain markets.
- Technical Limitations CRISPR applications in plants face challenges related to off-target effects and trait stability. Regulatory scrutiny and the need for long-term field trials add complexity to product development.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Demand for High-Yield Crops | +2.5% | Global | 2025–2035 |
| Advancements in CRISPR Technology | +1.5% | Global | 2025–2035 |
| Regulatory Support and Investment | +1.2% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High R&D Costs | −1.0% | Global | 2025–2029 |
| Public Acceptance and Labeling Concerns | −0.7% | Global | 2025–2029 |
| Technical Limitations | −0.5% | Global | 2025–2029 |
The market is segmented by product type and application, reflecting diverse breeding objectives and end-use requirements. Conventional and biotechnological methods serve distinct roles in crop improvement strategies.
Revenue share by type · 2025 base year
% OF $22.36 BN PLANT BREEDING AND CRISPR PLANTS MARKET · 2 TYPES COVERED
Each slice = that type's share of the total $22.36 Bn Plant Breeding and CRISPR Plants Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Conventional Breeding
-
CRISPR-based Gene Editing
-
Marker-assisted Selection
-
Genomic Selection
-
Tissue Culture
By application
-
Cereals & Grains (e.g
-
wheat
-
rice
-
corn
-
Oilseeds & Pulses (e.g
-
soybean
-
canola
-
lentils
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $22.36 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
Asia Pacific leads regional demand at ~43.0% in 2025. driven by manufacturing scale and end-market density
Per-region detail
-
Asia-Pacific
43% — China's rapid population growth and food demand drive investment in plant biotechnology
-
North America
30% — Strong R&D infrastructure and supportive regulatory frameworks facilitate CRISPR adoption
-
Europe
16% — Regulatory caution and public skepticism toward GMOs temper growth, though interest in gene-editing techniques is rising
-
Middle East & Africa
6% — Water scarcity and climate challenges create demand for drought-resistant crops
-
Latin America
5% — Adoption is driven by commodity crop sectors, particularly soy and corn
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The market exhibits moderate concentration, with leading agribusinesses and specialized biotech firms competing across regions. Innovation and regulatory compliance are key differentiators.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Nestle
Rank 01Share est. ~16%Revenue $102B FYHQ CH · Vevey -
PepsiCo
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Coca-Cola
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Unilever
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Kraft Heinz
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Mondelez
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Danone
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
General Mills
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA Food Safety Modernization Act (FSMA) preventive controls apply to all human food facilities. USDA FSIS inspects all meat/poultry. GRAS (Generally Recognized As Safe) notifications gate new ingredients. State-level labelling (California Prop 65) adds jurisdictional layers.
-
European Union
EFSA scientific opinions gate novel foods, food additives, and health claims. Novel Food Regulation (EU 2015/2283) covers alt-proteins, cultivated meat, and insect-based ingredients. Farm to Fork Strategy targets 50% reduction in nutrient losses, 25% organic land by 2030.
-
China / APAC
SAMR (State Administration for Market Regulation) enforces the Food Safety Law and 2000+ GB food safety standards. Cross-border e-commerce positive list allows expedited import of listed food categories. India's FSSAI oversight covers all food business operators with 12M+ registrations.
-
Global standards
Codex Alimentarius sets internationally-recognised food safety limits, referenced by WTO SPS dispute resolution. HACCP mandatory in most developed markets. ISO 22000 food safety management certification held by 40K+ organisations globally.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
• Who are the key players in the global plant breeding and CRISPR plants market?
Some key players operating in the global plant breeding and CRISPR plants market include Bayer AG, Sygneta AG, KWS Group, Corteva Agriscience, Limagrain, BASF SE, DLF Seeds A/S, Bioceres Crop Solutions, UPL Limited, Benson Hill Inc., Equinom Ltd., BioConsortia Inc., Hudson River Biotechnology -
• What are the factors driving the global plant breeding and CRISPR plants market?
The significance of sustainable crop production and the lowering cost of genomic solutions are two factors that are anticipated to propel the plant breeding and CRISPR plants market's development. -
• How big is the global plant breeding and CRISPR plants market?
The global plant breeding and CRISPR plants market size was estimated at USD 11.26 billion in 2021 and is expected to reach USD 34.36 billion in 2029. -
• What is the global plant breeding and CRISPR plants market growth?
The global plant breeding and CRISPR plants market is expected to grow at a compound annual growth rate of 14.97 % from 2023 to 2029 to reach USD 34.36 billion by 2029. -
• Which region accounted for the largest global plant breeding and CRISPR plants market share?
The Asia Pacific (APAC) dominated the global plant breeding and CRISPR plants market with a share of 34% in 2022.
The Plant Breeding and CRISPR Plants Market is projected to reach $38.19 Bn by 2035, up from $22.36 Bn in 2025 — a 5.50% CAGR equating to roughly 1.7× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.